{"id":"https://openalex.org/W7225450642","doi":"https://doi.org/10.12775/qs.2026.78.76517","title":"Efficacy of Olaparib in Women With BRCA2-Mutated Breast Cancer: A Critical Review of Clinical Evidence","display_name":"Efficacy of Olaparib in Women With BRCA2-Mutated Breast Cancer: A Critical Review of Clinical Evidence","publication_year":2026,"publication_date":"2026-11-06","ids":{"openalex":"https://openalex.org/W7225450642","doi":"https://doi.org/10.12775/qs.2026.78.76517"},"language":"en","primary_location":{"id":"doi:10.12775/qs.2026.78.76517","doi":"https://doi.org/10.12775/qs.2026.78.76517","is_oa":true,"landing_page_url":"https://doi.org/10.12775/qs.2026.78.76517","pdf_url":"https://apcz.umk.pl/QS/article/download/76517/48188","source":{"id":"https://openalex.org/S4210230959","display_name":"Quality in Sport","issn_l":"2450-3118","issn":["2450-3118"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":["ddh","erih-plus","norway-1","poland-20"],"host_organization":"https://openalex.org/P4310317346","host_organization_name":"Kazimierz Wielki University in Bydgoszcz","host_organization_lineage":["https://openalex.org/P4310317346"],"host_organization_lineage_names":["Kazimierz Wielki University in Bydgoszcz"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Quality in Sport","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://apcz.umk.pl/QS/article/download/76517/48188","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5092372764","display_name":"Bartosz Zara\u0144ski","orcid":"https://orcid.org/0009-0002-5952-694X","observed_orcids":["https://orcid.org/0009-0002-5952-694X"]},"institutions":[{"id":"https://openalex.org/I98559091","display_name":"University of Rzesz\u00f3w","ror":"https://ror.org/03pfsnq21","country_code":"PL","type":"education","lineage":["https://openalex.org/I98559091"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Bartosz Zara\u0144ski","raw_affiliation_strings":["College of Medical Sciences of University of Rzesz\u00f3w, al. Rejtana 16c, 35-959 Rzesz\u00f3w"],"raw_orcid":"https://orcid.org/0009-0002-5952-694X","affiliations":[{"raw_affiliation_string":"College of Medical Sciences of University of Rzesz\u00f3w, al. Rejtana 16c, 35-959 Rzesz\u00f3w","institution_ids":["https://openalex.org/I98559091"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5124512031","display_name":"Patryk Bachurski","orcid":"https://orcid.org/0009-0004-2021-7589","observed_orcids":["https://orcid.org/0009-0004-2021-7589"]},"institutions":[{"id":"https://openalex.org/I98559091","display_name":"University of Rzesz\u00f3w","ror":"https://ror.org/03pfsnq21","country_code":"PL","type":"education","lineage":["https://openalex.org/I98559091"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Patryk Bachurski","raw_affiliation_strings":["Uniwersytet Rzeszowski"],"raw_orcid":"https://orcid.org/0009-0004-2021-7589","affiliations":[{"raw_affiliation_string":"Uniwersytet Rzeszowski","institution_ids":["https://openalex.org/I98559091"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019882168","display_name":"Gabriela Chmiel","orcid":"https://orcid.org/0009-0009-8416-3598","observed_orcids":["https://orcid.org/0009-0009-8416-3598"]},"institutions":[{"id":"https://openalex.org/I98559091","display_name":"University of Rzesz\u00f3w","ror":"https://ror.org/03pfsnq21","country_code":"PL","type":"education","lineage":["https://openalex.org/I98559091"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Gabriela Chmiel","raw_affiliation_strings":["University of Rzesz\u00f3w - student"],"raw_orcid":"https://orcid.org/0009-0009-8416-3598","affiliations":[{"raw_affiliation_string":"University of Rzesz\u00f3w - student","institution_ids":["https://openalex.org/I98559091"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5146727288","display_name":"Pawe\u0142 Kalinowski","orcid":"https://orcid.org/0009-0003-1907-7868","observed_orcids":["https://orcid.org/0009-0003-1907-7868"]},"institutions":[{"id":"https://openalex.org/I98559091","display_name":"University of Rzesz\u00f3w","ror":"https://ror.org/03pfsnq21","country_code":"PL","type":"education","lineage":["https://openalex.org/I98559091"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Pawe\u0142 Kalinowski","raw_affiliation_strings":["Uniwersytet Rzeszowski"],"raw_orcid":"https://orcid.org/0009-0003-1907-7868","affiliations":[{"raw_affiliation_string":"Uniwersytet Rzeszowski","institution_ids":["https://openalex.org/I98559091"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5124472902","display_name":"Maja Mi\u0119dlar","orcid":"https://orcid.org/0009-0004-8612-8861","observed_orcids":["https://orcid.org/0009-0004-8612-8861"]},"institutions":[{"id":"https://openalex.org/I98559091","display_name":"University of Rzesz\u00f3w","ror":"https://ror.org/03pfsnq21","country_code":"PL","type":"education","lineage":["https://openalex.org/I98559091"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Maja Mi\u0119dlar","raw_affiliation_strings":["University of Rzesz\u00f3w"],"raw_orcid":"https://orcid.org/0009-0004-8612-8861","affiliations":[{"raw_affiliation_string":"University of Rzesz\u00f3w","institution_ids":["https://openalex.org/I98559091"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5124540851","display_name":"Martyna Muda","orcid":"https://orcid.org/0009-0008-1303-0985","observed_orcids":["https://orcid.org/0009-0008-1303-0985"]},"institutions":[{"id":"https://openalex.org/I98559091","display_name":"University of Rzesz\u00f3w","ror":"https://ror.org/03pfsnq21","country_code":"PL","type":"education","lineage":["https://openalex.org/I98559091"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Martyna Muda","raw_affiliation_strings":["University of Rzeszow"],"raw_orcid":"https://orcid.org/0009-0008-1303-0985","affiliations":[{"raw_affiliation_string":"University of Rzeszow","institution_ids":["https://openalex.org/I98559091"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5098715893","display_name":"Szymon Pacek","orcid":"https://orcid.org/0009-0003-6605-6074","observed_orcids":["https://orcid.org/0009-0003-6605-6074"]},"institutions":[{"id":"https://openalex.org/I98559091","display_name":"University of Rzesz\u00f3w","ror":"https://ror.org/03pfsnq21","country_code":"PL","type":"education","lineage":["https://openalex.org/I98559091"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Szymon Pacek","raw_affiliation_strings":["Rzesz\u00f3w University, Rzesz\u00f3w, Poland"],"raw_orcid":"https://orcid.org/0009-0003-6605-6074","affiliations":[{"raw_affiliation_string":"Rzesz\u00f3w University, Rzesz\u00f3w, Poland","institution_ids":["https://openalex.org/I98559091"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5124497435","display_name":"Elisabetta Pierzga","orcid":"https://orcid.org/0009-0003-1674-9462","observed_orcids":["https://orcid.org/0009-0003-1674-9462"]},"institutions":[{"id":"https://openalex.org/I98559091","display_name":"University of Rzesz\u00f3w","ror":"https://ror.org/03pfsnq21","country_code":"PL","type":"education","lineage":["https://openalex.org/I98559091"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Elisabetta Pierzga","raw_affiliation_strings":["Uniwersytet Rzeszowski"],"raw_orcid":"https://orcid.org/0009-0003-1674-9462","affiliations":[{"raw_affiliation_string":"Uniwersytet Rzeszowski","institution_ids":["https://openalex.org/I98559091"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010625763","display_name":"Karol Pawe\u0142 Wi\u015bniewski","orcid":"https://orcid.org/0000-0001-8736-0305","observed_orcids":["https://orcid.org/0000-0001-8736-0305","https://orcid.org/0009-0004-6561-5070"]},"institutions":[{"id":"https://openalex.org/I98559091","display_name":"University of Rzesz\u00f3w","ror":"https://ror.org/03pfsnq21","country_code":"PL","type":"education","lineage":["https://openalex.org/I98559091"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Karol Pawe\u0142 Wi\u015bniewski","raw_affiliation_strings":["Uniwersytet Rzeszowski"],"raw_orcid":"https://orcid.org/0009-0004-6561-5070","affiliations":[{"raw_affiliation_string":"Uniwersytet Rzeszowski","institution_ids":["https://openalex.org/I98559091"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5133712561","display_name":"Pawe\u0142 Witkowski","orcid":"https://orcid.org/0009-0002-1083-8424","observed_orcids":["https://orcid.org/0009-0002-1083-8424"]},"institutions":[{"id":"https://openalex.org/I98559091","display_name":"University of Rzesz\u00f3w","ror":"https://ror.org/03pfsnq21","country_code":"PL","type":"education","lineage":["https://openalex.org/I98559091"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Pawe\u0142 Witkowski","raw_affiliation_strings":["Uniwersytet Rzeszowski"],"raw_orcid":"https://orcid.org/0009-0002-1083-8424","affiliations":[{"raw_affiliation_string":"Uniwersytet Rzeszowski","institution_ids":["https://openalex.org/I98559091"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I98559091"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"78","issue":null,"first_page":"76517","last_page":"76517"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/olaparib","display_name":"olaparib","score":1.0},{"id":"https://openalex.org/keywords/brca2-mutation","display_name":"BRCA2 mutation","score":0.8180000185966492},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.796999990940094},{"id":"https://openalex.org/keywords/parp-inhibitors","display_name":"PARP inhibitors","score":0.8920000195503235},{"id":"https://openalex.org/keywords/homologous-recombination-deficiency","display_name":"homologous recombination deficiency","score":0.8640000224113464},{"id":"https://openalex.org/keywords/adjuvant-therapy","display_name":"adjuvant therapy","score":0.8190000057220459},{"id":"https://openalex.org/keywords/neoadjuvant-therapy","display_name":"neoadjuvant therapy","score":0.9509999752044678},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.9039999842643738},{"id":"https://openalex.org/keywords/her2-negative-breast-cancer","display_name":"HER2-negative breast cancer","score":0.9010000228881836},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.6370000243186951},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.800000011920929},{"id":"https://openalex.org/keywords/real-world-data","display_name":"real-world data","score":0.5120000243186951}],"concepts":[{"id":"https://openalex.org/C2779962180","wikidata":"https://www.wikidata.org/wiki/Q7083106","display_name":"Olaparib","level":5,"score":0.9537000060081482},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.845300018787384},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.7597000002861023},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6263999938964844},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.588100016117096},{"id":"https://openalex.org/C2779138821","wikidata":"https://www.wikidata.org/wiki/Q7118227","display_name":"PARP inhibitor","level":5,"score":0.48579999804496765},{"id":"https://openalex.org/C2780194787","wikidata":"https://www.wikidata.org/wiki/Q4836333","display_name":"BRCA mutation","level":4,"score":0.47999998927116394},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.4659999907016754},{"id":"https://openalex.org/C109825262","wikidata":"https://www.wikidata.org/wiki/Q1139164","display_name":"Germline","level":3,"score":0.3856000006198883},{"id":"https://openalex.org/C2777863537","wikidata":"https://www.wikidata.org/wiki/Q357896","display_name":"Adjuvant","level":2,"score":0.3756999969482422},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.3698999881744385},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3695000112056732},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.3677000105381012},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.3668000102043152},{"id":"https://openalex.org/C13514818","wikidata":"https://www.wikidata.org/wiki/Q5552256","display_name":"Germline mutation","level":4,"score":0.3440000116825104},{"id":"https://openalex.org/C2909462720","wikidata":"https://www.wikidata.org/wiki/Q421651","display_name":"BRCA2 Protein","level":5,"score":0.34150001406669617},{"id":"https://openalex.org/C2778502085","wikidata":"https://www.wikidata.org/wiki/Q7662767","display_name":"Synthetic lethality","level":4,"score":0.3330000042915344},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.29660001397132874},{"id":"https://openalex.org/C2780350996","wikidata":"https://www.wikidata.org/wiki/Q420532","display_name":"Vinorelbine","level":4,"score":0.2870999872684479},{"id":"https://openalex.org/C2776387010","wikidata":"https://www.wikidata.org/wiki/Q408717","display_name":"Eribulin","level":5,"score":0.2815000116825104},{"id":"https://openalex.org/C95190672","wikidata":"https://www.wikidata.org/wiki/Q815382","display_name":"Meta-analysis","level":2,"score":0.2583000063896179},{"id":"https://openalex.org/C3019894029","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Overall survival","level":2,"score":0.25619998574256897},{"id":"https://openalex.org/C32220436","wikidata":"https://www.wikidata.org/wiki/Q2072214","display_name":"Personalized medicine","level":2,"score":0.25279998779296875},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.25110000371932983}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.12775/qs.2026.78.76517","doi":"https://doi.org/10.12775/qs.2026.78.76517","is_oa":true,"landing_page_url":"https://doi.org/10.12775/qs.2026.78.76517","pdf_url":"https://apcz.umk.pl/QS/article/download/76517/48188","source":{"id":"https://openalex.org/S4210230959","display_name":"Quality in Sport","issn_l":"2450-3118","issn":["2450-3118"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":["ddh","erih-plus","norway-1","poland-20"],"host_organization":"https://openalex.org/P4310317346","host_organization_name":"Kazimierz Wielki University in Bydgoszcz","host_organization_lineage":["https://openalex.org/P4310317346"],"host_organization_lineage_names":["Kazimierz Wielki University in Bydgoszcz"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Quality in Sport","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.12775/qs.2026.78.76517","doi":"https://doi.org/10.12775/qs.2026.78.76517","is_oa":true,"landing_page_url":"https://doi.org/10.12775/qs.2026.78.76517","pdf_url":"https://apcz.umk.pl/QS/article/download/76517/48188","source":{"id":"https://openalex.org/S4210230959","display_name":"Quality in Sport","issn_l":"2450-3118","issn":["2450-3118"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":["ddh","erih-plus","norway-1","poland-20"],"host_organization":"https://openalex.org/P4310317346","host_organization_name":"Kazimierz Wielki University in Bydgoszcz","host_organization_lineage":["https://openalex.org/P4310317346"],"host_organization_lineage_names":["Kazimierz Wielki University in Bydgoszcz"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Quality in Sport","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225450642.pdf","grobid_xml":"https://content.openalex.org/works/W7225450642.grobid-xml"},"referenced_works_count":24,"referenced_works":["https://openalex.org/W2111437716","https://openalex.org/W2621271973","https://openalex.org/W2808864948","https://openalex.org/W2907672417","https://openalex.org/W2913584903","https://openalex.org/W3047848114","https://openalex.org/W3093265161","https://openalex.org/W3093760305","https://openalex.org/W3095107109","https://openalex.org/W3164115667","https://openalex.org/W3165576985","https://openalex.org/W4200611978","https://openalex.org/W4220913811","https://openalex.org/W4304084160","https://openalex.org/W4307816891","https://openalex.org/W4320717500","https://openalex.org/W4361006679","https://openalex.org/W4362505810","https://openalex.org/W4362566480","https://openalex.org/W4365512364","https://openalex.org/W4389978835","https://openalex.org/W4410315258","https://openalex.org/W7125938252","https://openalex.org/W7153442903"],"related_works":["https://openalex.org/W4361006679","https://openalex.org/W4415941470","https://openalex.org/W3167171623","https://openalex.org/W2795041963","https://openalex.org/W7162018878","https://openalex.org/W2622347503","https://openalex.org/W4283211017","https://openalex.org/W4226209951","https://openalex.org/W7204088122","https://openalex.org/W3127699912"],"abstract_inverted_index":{"Breast":[0],"cancers":[1],"with":[2,53,137],"pathogenic":[3],"BRCA2":[4,72,93,113,142],"variants":[5],"exhibit":[6],"impaired":[7],"homologous-recombination":[8],"DNA":[9],"repair,":[10],"increasing":[11],"vulnerability":[12],"to":[13],"PARP":[14,20],"inhibition.":[15],"Olaparib":[16],"is":[17,144],"the":[18,79,110,163,191],"best-studied":[19],"inhibitor":[21],"in":[22,109,184],"this":[23],"setting,":[24],"though":[25],"evidence":[26],"varies":[27],"across":[28],"disease":[29,178],"stages,":[30],"mutation":[31],"types,":[32],"and":[33,45,65,86,127,152,172],"treatment":[34,167],"contexts.":[35],"This":[36],"review":[37],"synthesizes":[38],"randomized":[39],"trials,":[40],"prospective":[41],"studies,":[42],"real-world":[43],"cohorts,":[44],"meta-analyses.":[46],"In":[47,75],"high-risk":[48],"HER2-negative":[49,76,209],"early":[50],"breast":[51,210],"cancer":[52],"germline":[54,207],"BRCA1/2":[55,125,154,217],"mutations,":[56],"1-year":[57],"adjuvant":[58],"olaparib":[59,176,200],"improved":[60],"invasive":[61],"disease-free,":[62,64],"distant":[63],"overall":[66,111],"survival":[67,84],"(OS),":[68],"demonstrating":[69],"a":[70,96],"consistent":[71],"subgroup":[73,94],"effect.":[74],"metastatic":[77,185],"disease,":[78],"OlympiAD":[80],"trial":[81],"showed":[82],"progression-free":[83],"(PFS)":[85],"response":[87],"advantages":[88],"over":[89],"chemotherapy.":[90,138],"The":[91,187],"prespecified":[92],"achieved":[95],"PFS":[97],"hazard":[98],"ratio":[99],"of":[100,165,193],"0.49,":[101],"although":[102],"OS":[103,183],"benefits":[104],"were":[105],"not":[106,129],"statistically":[107],"significant":[108],"or":[112,136],"populations.":[114],"Neoadjuvant":[115],"studies":[116,151],"show":[117],"substantial":[118],"activity":[119,160],"but":[120,146,212],"remain":[121],"small,":[122,149],"frequently":[123],"combine":[124],"carriers,":[126],"have":[128],"definitively":[130],"established":[131],"olaparib\u2019s":[132],"pre-surgical":[133],"role":[134],"alone":[135],"Evidence":[139,198],"for":[140,206],"somatic":[141],"mutations":[143],"promising":[145],"relies":[147],"on":[148],"single-arm":[150],"pooled":[153,216],"analyses.":[155,197],"Real-world":[156],"data":[157],"reproduce":[158],"clinical":[159],"while":[161],"highlighting":[162],"impact":[164],"later":[166],"lines,":[168],"prior":[169],"platinum":[170],"exposure,":[171],"patient":[173],"selection.":[174],"Overall,":[175],"improves":[177],"control":[179],"more":[180],"consistently":[181],"than":[182],"settings.":[186],"primary":[188],"limitation":[189],"remains":[190],"scarcity":[192],"adequately":[194],"powered":[195],"BRCA2-specific":[196,221],"supports":[199],"as":[201],"an":[202],"effective":[203],"targeted":[204],"therapy":[205],"BRCA2-mutated,":[208],"cancer,":[211],"cautions":[213],"against":[214],"assuming":[215],"results":[218],"automatically":[219],"represent":[220],"estimates.":[222]},"counts_by_year":[],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2026-11-08T00:00:00"}